Systematic overview of cost-effectiveness thresholds in ten countries across four continents

doi:10.2217/cer.15.38

. 2015 Sep;4(5):485-504.

doi: 10.2217/cer.15.38.

Systematic overview of cost-effectiveness thresholds in ten countries across four continents

Ruth Schwarzer^{1

2}, Ursula Rochau^{1

2}, Kim Saverno^{1

3}, Beate Jahn^{1

2}, Bernhard Bornschein¹, Nikolai Muehlberger¹, Magdalena Flatscher-Thoeni⁴, Petra Schnell-Inderst^{1

2}, Gaby Sroczynski^{1

2}, Martina Lackner¹, Imke Schall¹, Ansgar Hebborn⁵, Karl Pugner⁶, Andras Fehervary⁷, Diana Brixner^{1

2

3

8}, Uwe Siebert^{1

2

9

10}

Affiliations

¹ Department of Public Health, Health Services Research & Health Technology Assessment, Institute of Public Health, Medical Decision Making & Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics & Technology, Eduard Wallnoefer Center I, 6060 Hall i.T., Austria.
² Division of Public Health Decision Modelling, Health Technology Assessment & Health Economics, ONCOTYROL - Center for Personalized Cancer Medicine, Innrain 66a, 6020 Innsbruck, Austria.
³ Department of Pharmacotherapy, University of Utah, 30 South 2000, Salt Lake City, UT 84112, USA.
⁴ Program on Health Policy, Administration, Economics & Law, Department of Public Health & Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics & Technology, Eduard Wallnoefer Center I, 6060 Hall i.T., Austria.
⁵ F Hoffmann-La Roche AG, Market Access Policy, Grenzacher Str. 124, 4070 Basel, Switzerland.
⁶ Amgen, Department of Health Economics & Reimbursement, Dammstrasse 23, 6301 Zug, Switzerland.
⁷ Novartis International AG, Government Affairs Europe, Novartis Campus, Fabrikstrasse 1, 4002 Basel, Switzerland.
⁸ Program in Personalized Health Care, Outcomes Research Center, Department of Pharmacotherapy, University of Utah, 30 South 2000, Salt Lake City, UT 84112, USA.
⁹ Department of Health Policy & Management, Center for Health Decision Science, Harvard T.H. Chan School of Public Health, 718 Huntington Ave., Boston, MA 02115, USA.
¹⁰ Institute for Technology Assessment & Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 101 Merrimac Street, Boston, MA 02114-4724, USA.

PMID: 26490020
DOI: 10.2217/cer.15.38

Free article

Systematic overview of cost-effectiveness thresholds in ten countries across four continents

Ruth Schwarzer et al. J Comp Eff Res. 2015 Sep.

Free article

. 2015 Sep;4(5):485-504.

doi: 10.2217/cer.15.38.

Authors

Affiliations

¹ Department of Public Health, Health Services Research & Health Technology Assessment, Institute of Public Health, Medical Decision Making & Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics & Technology, Eduard Wallnoefer Center I, 6060 Hall i.T., Austria.
² Division of Public Health Decision Modelling, Health Technology Assessment & Health Economics, ONCOTYROL - Center for Personalized Cancer Medicine, Innrain 66a, 6020 Innsbruck, Austria.
³ Department of Pharmacotherapy, University of Utah, 30 South 2000, Salt Lake City, UT 84112, USA.
⁴ Program on Health Policy, Administration, Economics & Law, Department of Public Health & Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics & Technology, Eduard Wallnoefer Center I, 6060 Hall i.T., Austria.
⁵ F Hoffmann-La Roche AG, Market Access Policy, Grenzacher Str. 124, 4070 Basel, Switzerland.
⁶ Amgen, Department of Health Economics & Reimbursement, Dammstrasse 23, 6301 Zug, Switzerland.
⁷ Novartis International AG, Government Affairs Europe, Novartis Campus, Fabrikstrasse 1, 4002 Basel, Switzerland.
⁸ Program in Personalized Health Care, Outcomes Research Center, Department of Pharmacotherapy, University of Utah, 30 South 2000, Salt Lake City, UT 84112, USA.
⁹ Department of Health Policy & Management, Center for Health Decision Science, Harvard T.H. Chan School of Public Health, 718 Huntington Ave., Boston, MA 02115, USA.
¹⁰ Institute for Technology Assessment & Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 101 Merrimac Street, Boston, MA 02114-4724, USA.

PMID: 26490020
DOI: 10.2217/cer.15.38

Abstract

Aim: To provide an overview of thresholds for incremental cost-effectiveness ratios (ICERs) representing willingness-to-pay (WTP) across multiple countries and insights into exemptions pertaining to the ICER (e.g., cancer). To compare ICER thresholds to individual country's estimated ability-to-pay.

Materials & methods: We included AHRQ/USA, BIQG-GOEG/Austria, CADTH/Canada, DAHTA@DIMDI/Germany, DECIT-CGATS/Brazil, HAS/France, HITAP/Thailand, IQWiG/Germany, LBI-HTA/Austria, MSAC/Australia, NICE/England/Wales and SBU/Sweden. ICER thresholds were derived from systematic literature/website search/expert surveys. WTP was compared with ATP using Spearman's rank correlation.

Results: Two general and explicitly acknowledged thresholds (England/Wales, Thailand), implicit thresholds in six countries and different ICER thresholds/decision-making rules in oncology were identified. Correlation between WTP and ability-to-pay was moderate.

Discussion: Our overview supports country-specific discussions on WTP and on how to define value(s) within societies.

Keywords: cost–effectiveness thresholds; decision-making; health policy; reimbursement; technology assessment; willingness-to-pay.

PubMed Disclaimer

Cited by

Cost-effectiveness and cost-utility analysis of a nurse-led, transitional care model to improve care coordination for patients with cardiovascular diseases: results from the "Cardiolotse" study.
Coors M, Schüttig W, Reber KC, Darius H, Holzgreve A, Karmann S, Stürtz A, Zöller R, Kropp S, Riesner P, Sundmacher L. Coors M, et al. Eur J Health Econ. 2024 Nov 6. doi: 10.1007/s10198-024-01734-7. Online ahead of print. Eur J Health Econ. 2024. PMID: 39503813
Thresholds for the value judgement of health technologies in the United Arab Emirates: a consensus approach through voting sessions.
Aldallal S, Farghaly M, Fahmy S, Alnaqbi KA, Al Naeem W, Alsaadi M, Moukarzel M, Nader Fasseeh A, Korra N, Abaza S, Kaló Z. Aldallal S, et al. BMJ Open. 2024 Nov 4;14(11):e090344. doi: 10.1136/bmjopen-2024-090344. BMJ Open. 2024. PMID: 39496369 Free PMC article.
Cost-Utility of Venoarterial Extracorporeal Membrane Oxygenation in Refractory Cardiogenic Shock: A Brazilian Perspective Study.
Decker SRDR, Wainstein RV, Scolari FL, Rosa PRD, Schneider D, Fogazzi DV, Trott G, Wolf J, Teixeira C, Rover MM, Nasi LA, Rohde LE, Polanczyk CA, Rosa RG, Bertoldi EG. Decker SRDR, et al. Arq Bras Cardiol. 2024 Jul;121(8):e20230672. doi: 10.36660/abc.20230672. Arq Bras Cardiol. 2024. PMID: 39194041 Free PMC article. English, Portuguese.
Cost-effectiveness of applying high-sensitivity troponin I to a score for cardiovascular risk prediction in asymptomatic population.
Jülicher P, Makarova N, Ojeda F, Giusepi I, Peters A, Thorand B, Cesana G, Jørgensen T, Linneberg A, Salomaa V, Iacoviello L, Costanzo S, Söderberg S, Kee F, Giampaoli S, Palmieri L, Donfrancesco C, Zeller T, Kuulasmaa K, Tuovinen T, Lamrock F, Conrads-Frank A, Brambilla P, Blankenberg S, Siebert U. Jülicher P, et al. PLoS One. 2024 Jul 19;19(7):e0307468. doi: 10.1371/journal.pone.0307468. eCollection 2024. PLoS One. 2024. PMID: 39028718 Free PMC article.
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges.
Espinosa O, Rodríguez-Lesmes P, Romano G, Orozco E, Basto S, Ávila D, Mesa L, Enríquez H. Espinosa O, et al. Appl Health Econ Health Policy. 2024 Nov;22(6):797-804. doi: 10.1007/s40258-024-00900-5. Epub 2024 Jul 12. Appl Health Econ Health Policy. 2024. PMID: 38995492 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Systematic overview of cost-effectiveness thresholds in ten countries across four continents

Affiliations

Systematic overview of cost-effectiveness thresholds in ten countries across four continents

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources